New Search

Export article
Open Access

Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer

Jan A. Stratmann , Raphael Lacko, Olivier Ballo, Shabnam Shaid, Wolfgang Gleiber, Maria J. G. T. Vehreschild, Thomas Wichelhaus, Claudia Reinheimer, Stephan Göttig, Volkhard A. J. Kempf, Peter Kleine, Susanne Stera, Christian Brandts, Martin Sebastian, Sebastian Koschade
Published: 25 November 2020
PLoS ONE , Volume 15; doi:10.1371/journal.pone.0242544

Abstract: Objectives Multidrug-resistant organisms (MDRO) are considered an emerging threat worldwide. Data covering the clinical impact of MDRO colonization in patients with solid malignancies, however, is widely missing. We sought to determine the impact of MDRO colonization in patients who have been diagnosed with Non-small cell lung cancer (NSCLC) who are at known high-risk for invasive infections. Materials and methods Patients who were screened for MDRO colonization within a 90-day period after NSCLC diagnosis of all stages were included in this single-center retrospective study. Results Two hundred and ninety-five patients were included of whom 24 patients (8.1%) were screened positive for MDRO colonization (MDROpos) at first diagnosis. Enterobacterales were by far the most frequent MDRO detected with a proportion of 79.2% (19/24). MDRO colonization was present across all disease stages and more present in patients with concomitant diabetes mellitus. Median overall survival was significantly inferior in the MDROpos study group with a median OS of 7.8 months (95% CI, 0.0–19.9 months) compared to a median OS of 23.9 months (95% CI, 17.6–30.1 months) in the MDROneg group in univariate (p = 0.036) and multivariate analysis (P = 0.02). Exploratory analyses suggest a higher rate of non-cancer-related-mortality in MDROpos patients compared to MDROneg patients (p = 0.002) with an increased rate of fatal infections in MDROpos patients (p = 0.0002). Conclusions MDRO colonization is an independent risk factor for inferior OS in patients diagnosed with NSCLC due to a higher rate of fatal infections. Empirical antibiotic treatment approaches should cover formerly detected MDR commensals in cases of (suspected) invasive infections.
Keywords: Cancer immunotherapy / Cancer detection and diagnosis / Cancer Treatment / non-small cell lung cancer / antibiotics / Species Colonization / methicillin-resistant Staphylococcus aureus / Cancer Risk Factors

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

Share this article

Click here to see the statistics on "PLoS ONE" .
References (64)
    Back to Top Top